Skip to main content

JHOP - December 2021 Vol 11, No 6

Original Article

FDA Oncology Update

AVBCC 2021 Highlights

ESMO 2021 Highlights

Dosing Chemotherapy in Obese Patients, Still Not Answered

By Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Hypersensitivity Reactions to Taxanes and Subsequent Treatment with Nab-Paclitaxel: Case Reports of 2 Women with Early-Stage Breast Cancer

Kevin Straughn, PharmD; Robin Hardie-Hood, MD; Jordan Carrera, PharmD, BCPS, BCOP

Original Article

Impact of Using Adjusted Body Surface Area in Obese Patients Receiving Ablative Busulfan plus Fludarabine Conditioning Regimen Before Hematopoietic Stem-Cell Transplant

Katelyn A. Zink, PharmD, BCOP; Jill Stein, PharmD, BCOP; Patrick Ten Eyck, MS, PhD; Meredith Ginn, PharmD, BCOP

Evaluating Antibiotic Use and Opportunities for Intervention in Patients with Cancer

Corey Medler, PharmD, MPH; Rachel Kenney, PharmD, BCIDP; Susan Davis, PharmD

CAR T-Cell Therapy: Review of the Newest Weapon in the Battle Against Hematologic Malignancies

Dennis Marjoncu, PharmD, BCOP

FDA Oncology Update

Cytalux, a Novel Imaging Agent, FDA Approved for Diagnosing Inoperable Ovarian Cancer Lesions

FDA Approved Fyarro for Malignant Perivascular Epithelioid-Cell Tumor

Oral Scemblix FDA Approved for Patients with Ph-Positive Chronic Myeloid Leukemia

Darzalex Faspro, Kyprolis, and Dexamethasone a New Combination FDA Approved for Multiple Myeloma

Keytruda Now FDA Approved for Adjuvant Treatment of Renal-Cell Carcinoma

Tecentriq First Immunotherapy FDA Approved for Adjuvant Treatment of Early-Stage Non–Small-Cell Lung Cancer

Keytruda plus Chemotherapy FDA Approved for First-Line Treatment of Cervical Cancer

Verzenio with Endocrine Therapy FDA Approved for Adjuvant Treatment of Early Breast Cancer

Tecartus FDA Approved for Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

AVBCC 2021 Highlights

Meeting Highlights Online First

The Impact of Telehealth on Cancer Care

Meeting Highlights Online First

The Oncology Pipeline Overview: Recent Approvals and Near-Term Drugs

Online First Meeting Highlights

Medically Integrated Oncology Pharmacy Promotes Patient-Centric Care

Online First Meeting Highlights

Drug Price Reform with Value in Mind: Can It Happen?

ESMO 2021 Highlights

Online First Meeting Highlights

Study Shows mRNA COVID-19 Vaccine Effective and Safe in Patients with Cancer Undergoing Treatment

Online First Meeting Highlights

Trastuzumab Deruxtecan Tops Trastuzumab Emtansine as Second-Line Therapy in HER2-Positive Metastatic Breast Cancer

Online First Meeting Highlights

Abiraterone Added to Androgen-Deprivation Therapy Significantly Improves Metastasis-Free Survival in Patients with High-Risk Prostate Cancer

Online First Meeting Highlights

Adagrasib Shows Promising Activity in Metastatic Colorectal Cancer